97 related articles for article (PubMed ID: 27098015)
1. Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential.
Dubois N; Willems M; Nguyen-Khac MT; Kroonen J; Goffart N; Deprez M; Bours V; Robe PA
Int J Oncol; 2016 Jun; 48(6):2445-52. PubMed ID: 27098015
[TBL] [Abstract][Full Text] [Related]
2. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
Dixit D; Sharma V; Ghosh S; Mehta VS; Sen E
Cell Death Dis; 2012 Feb; 3(2):e271. PubMed ID: 22318540
[TBL] [Abstract][Full Text] [Related]
4. Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells.
Kroonen J; Artesi M; Capraro V; Nguyen-Khac MT; Willems M; Chakravarti A; Bours V; Robe PA
Int J Oncol; 2012 Aug; 41(2):776-82. PubMed ID: 22614258
[TBL] [Abstract][Full Text] [Related]
5. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
Pucko E; Ostrowski R; Matyja E
Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.
Pizzi M; Piazza F; Agostinelli C; Fuligni F; Benvenuti P; Mandato E; Casellato A; Rugge M; Semenzato G; Pileri SA
Oncotarget; 2015 Mar; 6(9):6544-52. PubMed ID: 25788269
[TBL] [Abstract][Full Text] [Related]
7. The role of protein kinase CK2 in glioblastoma development.
Ji H; Lu Z
Clin Cancer Res; 2013 Dec; 19(23):6335-7. PubMed ID: 24166907
[TBL] [Abstract][Full Text] [Related]
8. CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.
Dixit D; Ahmad F; Ghildiyal R; Joshi SD; Sen E
Exp Cell Res; 2016 May; 344(1):132-142. PubMed ID: 27001465
[TBL] [Abstract][Full Text] [Related]
9. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
Eddy SF; Guo S; Demicco EG; Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2005 Dec; 65(24):11375-83. PubMed ID: 16357145
[TBL] [Abstract][Full Text] [Related]
10. Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.
Kang YJ; Balter B; Csizmadia E; Haas B; Sharma H; Bronson R; Yan CT
Nat Commun; 2017 Jan; 8():14013. PubMed ID: 28094268
[TBL] [Abstract][Full Text] [Related]
11. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
12. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.
Raychaudhuri B; Han Y; Lu T; Vogelbaum MA
J Neurooncol; 2007 Oct; 85(1):39-47. PubMed ID: 17479228
[TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α.
Liu J; Cao XC; Xiao Q; Quan MF
Mol Med Rep; 2015 Jan; 11(1):665-9. PubMed ID: 25334018
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.
Quotti Tubi L; Canovas Nunes S; Brancalion A; Doriguzzi Breatta E; Manni S; Mandato E; Zaffino F; Macaccaro P; Carrino M; Gianesin K; Trentin L; Binotto G; Zambello R; Semenzato G; Gurrieri C; Piazza F
Leukemia; 2017 Feb; 31(2):292-300. PubMed ID: 27479180
[TBL] [Abstract][Full Text] [Related]
15. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
Schneider CC; Hessenauer A; Montenarh M; Götz C
Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
17. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
18. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells.
Kaminska B; Ellert-Miklaszewska A; Oberbek A; Wisniewski P; Kaza B; Makowska M; Bretner M; Kazimierczuk Z
Int J Oncol; 2009 Nov; 35(5):1091-100. PubMed ID: 19787263
[TBL] [Abstract][Full Text] [Related]
20. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
